Key Insights

Highlights

Success Rate

91% trial completion (above average)

Published Results

18 trials with published results (9%)

Research Maturity

113 completed trials (57% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.6%

11 terminated out of 198 trials

Success Rate

91.1%

+4.6% vs benchmark

Late-Stage Pipeline

24%

47 trials in Phase 3/4

Results Transparency

16%

18 of 113 completed with results

Key Signals

18 with results91% success11 terminated

Data Visualizations

Phase Distribution

121Total
Not Applicable (57)
P 1 (5)
P 2 (12)
P 3 (15)
P 4 (32)

Trial Status

Completed113
Unknown42
Terminated11
Recruiting11
Active Not Recruiting10
Withdrawn5

Trial Success Rate

91.1%

Benchmark: 86.5%

Based on 113 completed trials

Clinical Trials (198)

Showing 20 of 20 trials
NCT03392415Not ApplicableActive Not Recruiting

The NOrdic-Baltic Randomized Registry Study for Evaluation of PCI in Chronic Total Coronary Occlusion

NCT07449325Not ApplicableNot Yet RecruitingPrimary

Self Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD)

NCT04175626Completed

Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

NCT07432620Active Not Recruiting

Artificial Intelligence Stress Echo (FINESSE) Project

NCT04475380Completed

Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents

NCT02253108Not ApplicableActive Not Recruiting

The OCT SORT-OUT VIII Study

NCT06708000Phase 3Enrolling By Invitation

Personalized Evaluation of Susptected Myocardial Ischemia

NCT07258290Not ApplicableNot Yet Recruiting

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

NCT04774913Not ApplicableActive Not Recruiting

Invest-CTO PCI Trial

NCT07091682Not ApplicableRecruiting

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions

NCT05540223Not ApplicableRecruiting

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System

NCT02710435Active Not RecruitingPrimary

REDUCER-I: An Observational Study of the Neovasc Reducer™ System

NCT06348875Not Yet Recruiting

Clinical Evaluation of Radiation Reduction for Optimized Safety

NCT06808321Enrolling By Invitation

Benidipine in Hypertensive and/or Chronic Coronary Syndrome Patients

NCT05380063Phase 4Completed

Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting

NCT06181799Completed

Volatilome and Single-Lead Electrocardiogram Optimize Ischemic Heart Disease Diagnosis Using Machine Learning Models

NCT06480097Active Not RecruitingPrimary

Bidirectional Cohort Study on Improvement of Quality of Life in Patients After Coronary Intervention With Kuanxiong Aerosol

NCT03646760Not ApplicableCompleted

The Improving ATTENDance to Cardiac Rehabilitation Trial

NCT06164977Not ApplicableCompletedPrimary

Chronic Total Coronary Occlusion Treatment Results 6 Years After Bioresorbable Scaffold Implantation

NCT05493904Not ApplicableActive Not Recruiting

PREcise Percutaneous Coronary Intervention for Stent OptimizatION in Treatment of COMPLEX Lesion (PRECISION-COMPLEX)

Scroll to load more

Research Network

Activity Timeline